CTOs on the Move

CereVasc

www.cerevasc.com

 
The CereVasc eShunt™ device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.cerevasc.com
  • 2120 Commonwealth Avenue Suite 1
    Auburndale, MA USA 02466
  • Phone: N/A

Executives

Name Title Contact Details

Funding

CereVasc raised $44M on 06/09/2020

Similar Companies

Forum Pharmaceuticals

FORUM Pharmaceuticals Inc. (“FORUM Pharmaceuticals” or “FORUM”) is dedicated to developing transformative medicines to restore the minds of people with serious brain disease, empowering them to preserve their identity, dignity and the essence of what makes us human. The Company`s diverse pipeline is focused on discovering and developing new treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provide improvement in cognitive and overall function. FORUM is privately owned and based in Waltham, Mass.

BioLuminate

BioLuminate is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viridian Therapeutics

Viridian Therapeutics focuses in advancing new treatments for patients with diseases that are underserved by today`s therapies.

Quincy Bioscience

Quincy Bioscience is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TLC Biopharmaceuticals

TLC Biopharmaceuticals is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.